Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Hongkong
1 trial · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleOral-ATO for TP53-mutated Myeloid Malignancies
- Where
- Hong Kong
- Életkor
- 18 év and over
- People
- 30
- Run by
- The University of Hong Kong
See details and how to joinNCT06778187